| Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer A Fujimoto, M Furuta, Y Totoki, T Tsunoda, M Kato, Y Shiraishi, H Tanaka, ... Nature genetics 48 (5), 500-509, 2016 | 694 | 2016 |
| Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma BA Walker, EM Boyle, CP Wardell, A Murison, DB Begum, NM Dahir, ... Journal of clinical oncology 33 (33), 3911-3920, 2015 | 632 | 2015 |
| Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma BA Walker, K Mavrommatis, CP Wardell, TC Ashby, M Bauer, FE Davies, ... Blood, The Journal of the American Society of Hematology 132 (6), 587-597, 2018 | 422 | 2018 |
| A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis BA Walker, K Mavrommatis, CP Wardell, TC Ashby, M Bauer, F Davies, ... Leukemia 33 (1), 159-170, 2019 | 418 | 2019 |
| A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial KD Boyd, FM Ross, L Chiecchio, GP Dagrada, ZJ Konn, WJ Tapper, ... Leukemia 26 (2), 349-355, 2012 | 416 | 2012 |
| Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing L Rasche, SS Chavan, OW Stephens, PH Patel, R Tytarenko, C Ashby, ... Nature communications 8 (1), 268, 2017 | 359 | 2017 |
| Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms BA Walker, CP Wardell, L Melchor, A Brioli, DC Johnson, MF Kaiser, ... Leukemia 28 (2), 384-390, 2014 | 346 | 2014 |
| APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma BA Walker, CP Wardell, A Murison, EM Boyle, DB Begum, NM Dahir, ... Nature communications 6 (1), 6997, 2015 | 336 | 2015 |
| Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations CP Wardell, M Fujita, T Yamada, M Simbolo, M Fassan, R Karlic, P Polak, ... Journal of hepatology 68 (5), 959-969, 2018 | 315 | 2018 |
| Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma BA Walker, CP Wardell, L Chiecchio, EM Smith, KD Boyd, A Neri, ... Blood, The Journal of the American Society of Hematology 117 (2), 553-562, 2011 | 314 | 2011 |
| Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t (4; 14) and t (11; 14) myeloma BA Walker, CP Wardell, L Melchor, S Hulkki, NE Potter, DC Johnson, ... Blood, The Journal of the American Society of Hematology 120 (5), 1077-1086, 2012 | 313 | 2012 |
| Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma L Melchor, A Brioli, CP Wardell, A Murison, NE Potter, MF Kaiser, ... Leukemia 28 (8), 1705-1715, 2014 | 289 | 2014 |
| Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival KD Boyd, FM Ross, BA Walker, CP Wardell, WJ Tapper, L Chiecchio, ... Clinical cancer research 17 (24), 7776-7784, 2011 | 227 | 2011 |
| Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients BA Walker, CP Wardell, A Brioli, E Boyle, MF Kaiser, DB Begum, NB Dahir, ... Blood cancer journal 4 (3), e191-e191, 2014 | 213 | 2014 |
| Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells BA Walker, CP Wardell, DC Johnson, MF Kaiser, DB Begum, NB Dahir, ... Blood, The Journal of the American Society of Hematology 121 (17), 3413-3419, 2013 | 204 | 2013 |
| Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma MF Kaiser, DC Johnson, P Wu, BA Walker, A Brioli, F Mirabella, ... Blood, The Journal of the American Society of Hematology 122 (2), 219-226, 2013 | 196 | 2013 |
| Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma L Rasche, D Alapat, M Kumar, G Gershner, J McDonald, CP Wardell, ... Leukemia 33 (7), 1713-1722, 2019 | 137 | 2019 |
| The clinical impact and molecular biology of del (17p) in multiple myeloma treated with conventional or thalidomide‐based therapy KD Boyd, FM Ross, WJ Tapper, L Chiecchio, GP Dagrada, ZJ Konn, ... Genes, chromosomes and cancer 50 (10), 765-774, 2011 | 113 | 2011 |
| The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma A Mikulasova, CP Wardell, A Murison, EM Boyle, GH Jackson, J Smetana, ... Haematologica 102 (9), 1617, 2017 | 110 | 2017 |
| Cancer whole-genome sequencing: present and future H Nakagawa, CP Wardell, M Furuta, H Taniguchi, A Fujimoto Oncogene 34 (49), 5943-5950, 2015 | 106 | 2015 |
Brian A WalkerIndiana University在 iu.edu 的电子邮件经过验证
